MDR Organisms in Holy Family Hospital Rawalpindi

Slides:



Advertisements
Similar presentations
TREATMENT FOR SUPERIMPOSED PSEUDOMONAS AERUGINOSA INFECTION.
Advertisements

Monotherapy Versus Combination Therapy
East Texas Medical Center – Tyler Annual Physician Education MDRO -Multidrug-Resistant Organisms- Revised: April 2013.
2011 National Environmental Health Association Meeting Crispin Pierce, Sasha Showsh, and Eli Gottfried (faculty) Tola Ekunsanmi, Michael Checkai, Jay Nielsen,
Enoch Omonge University of Nairobi
Antimicrobial Susceptibility Testing – Part II
Treatment of Infection Professor Mark Pallen. Treatment of Infection How Do Antimicrobials Work? Key concept: selective toxicity –the antimicrobial agent.
Antibiotics and genetic variation in bacteria. Objectives Antibiotics Antibiotics don’t work against viruses. Antibiotics may be used to treat bacterial.
Sorting Out Antibiotics: A systematic approach to antibiotic selection Kenneth Alexander, M.D., Ph.D. Associate Professor of Pediatrics and Microbiology.
Antibiotics and Antibiotic Resistance. Antibiotics Antibiotics are powerful medicines that fight bacterial infection Literal translation anti – against.
Antibiotic Primer Jen Nicol PGY-2 Dr. Sue Kuhn Dr. McPherson May 19, 2011.
ANTIBIOTICS.
MRSA Definition Methicillin-resistant Staphylococcus aureus (MRSA) is a bacterium responsible for difficult-to-treat infections in humans. MRSA is by definition.
Chapter 1: Introduction to the resistance problem.
Optimizing Antibiotics Dr Samir Sahu. Time to Antimicrobial Therapy KHL.
Culture and Sensitivity Helping the Infection Preventionist Interpret Antibiograms Walter Phillips, BS, MS, PhD Director of Microbiology TriStar Healthcare.
(methicillin-resistant Staphylococcus aureus)
The evolution of antibiotic resistance Rob Knell / Lars Chittka.
Train-the-Trainer Understanding multidrug-resistance: Focus on Carbapenems Customize this presentation with your organization’s logo, etc. 13/17/2014.
Introduction to Antimicrobial Resistance and Antibiotic Stewardship
Antibiotic Pearls in the Emergency Department
Clinical Cases Beta-Lactam Answers. Case 1 What antibiotic would you recommend for intravenous therapy in a 40yo BM with a Staphylococcus aureus (MSSA)
Ranking of Antimicrobial Drugs According to Importance in Human Medicine John H. Powers, M.D. Lead Medical Officer Antimicrobial Drug Development and Resistance.
Adham Abu Taha, PhD Dept. of Pharmacology and Toxicology, College of Pharmacy, An-Najah National University, Nablus, Palestine Antimicrobial resistance.
 At the end of the lecture, students should :  Describe briefly common types of meningitis  Describe the principles of treatment  List the name of.
Zunilda Djanun*, Rudyanto S**, Yulia Rosa***, *Dept. Clinical Pharmacology FMUI/CMH, **ICU CMH, *** Dept. Clinical Microbiology FMUI.
Panton-Valentine Leukocidin (PVL) is a toxin that destroys white blood cells and is a virulence factor in some strains of Staphylococcus aureus. PVL occurs.
Antibiotics Foundation Block
Inhibiting Microbial Growth in vivo CLS 212: Medical Microbiology.
Antimicrobial Resistance patterns among nosocomial gram negative bacilli by E-test and disc diffusion methods in Sina and Imam Hospital.
Pharmacology Unit 2: Applied Surgical Pharmacology Elsevier items and derived items © 2006 by Saunders, an imprint of Elsevier Inc.
Common ID Syndromes March 2014.
Chapter 15: Antimicrobial Drugs ChemotherapyThe use of drugs to treat a disease Antimicrobial drugsInterfere with the growth of microbes within a host.
Impetigo The best topical agent is mupirocin; other agents, such as bacitracin and neomycin, are less effective. Patients who have numerous lesions or.
Hospital Acquired Pneumonia(HAP): is defined as a pneumonia which occurs after 48 hours of admission to hospital. Hospital Acquired Pneumonia(HAP): is.
Let’s Really Implement Antimicrobial Stewardship Chris Gentry, Pharm.D., BCPS Clinical Coordinator and Clinical Specialist, Infectious Diseases Oklahoma.
Empirical Therapy for Ventilation Associated Pneumonia Azar. Hadadi Associate Professor of Infectious Diseases.
Bacteria and antibiotics Page refs for this section = Textbook p
Chapter 20-Antimicrobial Agents _______________:The use of drugs to treat a disease (not necessarily infectious) Antimicrobial drugs: Interfere with the.
THINGS TO BE DISCUSSED Multi resistance antimicrobials Effects of some Antibiotics Research article Case study Future Horizons.
Antibiotics Affecting the Bacterial Cell Wall
Antimicrobial drugs. Antimicrobial drugs are effective in the treatment of infections because of their selective toxicity (that is, they have the ability.
EARS-Net data on Antimicrobial Resistance in Ireland, Q3 2015
Holy Family Catholic High School 17th April 2007 Developing medicines + Immunity UNIT 11.4 Controlling infectious disease Form 10 A4.
Inhibiting Microbial Growth in vivo CLS 212: Medical Microbiology.
Production of variation Selection for/against  Pop evolves:  cumulative change in heritable characteristics in population  Nat sel can act on pop w/o.
MICROBIOLOGICAL EPIDEMIOLOGY OF RESPIRATORY SPECIMENS IN ICU PATIENTS Dr Farooq Cheema, Dr Waseem Tariq, Dr Raja Ishtiaq, Dr Tabassum Qureshi, Dr Vincent.
Dr. Laila M. Matalqah Ph.D. Pharmacology
Lesson Overview Lesson Overview Diseases Caused by Bacteria and Viruses Lesson Overview 20.3 Diseases Caused by Bacteria and Viruses.
Using Nursing Home Antibiograms To Improve Antibiotic Prescribing and Delivery Training Slides for Nursing Home Nurses Comprehensive Antibiogram Toolkit.
Antibiotics (anti-microbials)
IMPORTANT ANTIBIOTICS AND ANTIMICROBIAL RESISTANCE A Presentation By Ms R.Venkatajothi, MSc., MPhil, PhD Senior Lecturer Department of Microbiology Faculty.
HAP and VAP Guidelines Update
Tapasyapreeti Mukhopadhyay, Vrushali Patwardhan, Sarman Singh
Kiran Ghimire, Baral B., Karna S., Baral M.P. PhD
Chapter 9.
Antibiotic Resistance
Antibiotics therapy in pediatrics
The Role of the Microbiology Laboratory in AMS programs
MEDICAL MICROBIOLOGY ANTIBIOTICS AND CHEMOTHERAPEUTICS: AN OVERVIEW
Antibiotics sensitivity of microorganism causing nosocomial infections
Development of resistance in Pseudomonas aeruginosa obtained from patients with cystic fibrosis at different times  F.B. Spencker, L. Staber, T. Lietz,
Chemotherapeutic agent
A multicentre analysis of epidemiology of the nosocomial bloodstream infections in Japanese university hospitals  M. Nagao  Clinical Microbiology and.
The need for new antibiotics
Multicenter study of the in vitro activity of cefepime in comparison with five other broad- spectrum antibiotics against clinical isolates of Gram-positive.
Antibiotic Resistance
Antimicrobial resistance
Presentation transcript:

MDR Organisms in Holy Family Hospital Rawalpindi An Antibiogram Pathology Department Holy Family Hospital Rawalpindi Medical College

Antimicrobial resistance is the ability of microorganisms that cause disease to withstand attack by antimicrobial agents. From drugs used to treat common bacterial infections, to the complex combinations, resistance is increasingly being detected and is spreading rapidly.

Antibiotic-resistant bacteria with the potential to cause untreatable infections pose "a catastrophic threat" to the population.

Antibiotic resistance evolves naturally via natural selection through random mutation, but it could also be engineered by applying an evolutionary stress on a population.

Once such a gene is generated, bacteria can then transfer the genetic information in a horizontal fashion (between individuals) by plasmid exchange. If a bacterium carries several resistance genes, it is called multi resistant or, informally, a superbug.

While a new infectious disease has been discovered nearly every year over the past 30 years, there have been very few new antibiotics developed leaving our armour nearly empty as diseases evolve and become resistant to existing drugs. ICU has highest rate of infection.

Case I of multidrug resistant SUPERBUG isolated from MICU HFH, Rawalpindi

Sensitive to POLYMYXIN Resistant to Augmentin Ceftazidime Ceftriaxone Specimen I ETT tip C/S Report : Coliform Spp Sensitive to IMIPENEM Resistant to Augmentin Ceftazidime Ceftriaxone Ciprofloxacin Tazocin Sulzone Gentamicin Specimen II C/S Report: Coliform Spp. Sensitive to POLYMYXIN Resistant to Augmentin Ceftazidime Ceftriaxone Ciprofloxacin Imipenem Tazocin Sulzone Gentamicin

Case II Sensitive Resistant Polymyxin Imipenem Sulzone Aztreonam Wound C/S received from Burn Unit C/S Report: Pseudomonas aeruginosa, heavy growth Sensitive Polymyxin Resistant Imipenem Sulzone Aztreonam Ceftazidime Tazocin Gentamicin Ciprofloxacin Cefepime

Case III Sensitive Resistant Nitrofurantoin Methicillin Vancomycin Urine C/S received from MICU C/S Report: Staphylococcus aureus. >105 cfu/ml Sensitive Nitrofurantoin Vancomycin Teicoplanin Resistant Methicillin Clarithromycin Penicillin Ciprofloxacin Gentamicin Co-Trimoxazole

HOLY FAMILY HOSPITAL RAWALPINDI 4 MONTH ANTIBIOGRAM. 1. 12. 2014 TO 31

Percentage of Sensitivity Coliforms Spp n=436 Percentage of Sensitivity Antibiotic Medical Surgical ICU OPD AMIKACIN 46 74 70 88 AMPICILLIN 07 9 - 16 CEFTAZIDIME 10 23 31 CEFTRIXONE 13 08 35 CIPROFLOXACIN 21 36 37 TAZOCIN 41 54 34 80 CO-TRIMAXAZOLE 27 17 SULZONE 33 61 44 76 IMIPENEM 81 83 73 94 CEFEPIME 58 42 57 NITROFURANTOIN 100 MEROPENEM 92 66 89 GENTAMICIN 60

Pseudomonas aeruginosa n=172 Percentage of Sensitivity Antibiotic Medical Surgical ICU OPD POLYMYXIN 97 100 AMIKACIN 28 41 67 65 CEFTAZIDIME 05 07 - 06 CEFTRIXONE 04 14 33 CARBENCILLIN 09 11 CIPROFLOXACIN 49 25 40 63 TAZOCIN 35 39 55 71 SULZONE 24 08 IMIPENEM 62 69 57 74 GENTAMICIN 12 50 CEFEPIME 43

Staphylococcus aureus (Including MRSA) n=91 Percentage of Sensitivity Antibiotic Medical Surgical ICU OPD METHICILLIN 20 55 15 TEICOPLANIN 100 VANCOMYCIN CHLORAMPHENICOL 90 - GENTAMICIN 27 25 63 CIPROFLOXACIN 11 38 14 COTRIMOXAZOLE 40 33 LINEZOLID

Staphylococcus spp (Coagulase Negative) n=57 Percentage of Sensitivity Antibiotic Medical Surgical ICU OPD METHICILLIN 50 52 TEICOPLANIN 100 VANCOMYCIN CHLORAMPHENICOL 48 - 75 GENTAMICIN 65 08 30 CIPROFLOXACIN 36 LINEZOLID

Acinetobacter Spp (n = 63) percentage of sensitivity Antibiotic Medical Surgical ICU OPD AMPICILLIN POLYMYXIN 100 AMIKACIN 05 20 CEFTAZIDIME CEFTRIXONE CIPROFLOXACIN 27 COTRIMOXAZOLE 12 06 TAZOCIN SULZONE 02 33 IMIPENEM 30 67 CEFEPIME - GENTAMICIN 40

EMPIRICAL ANTIBIOTICS FOR SEPSIS/ SEPTIC SHOCK Gram positive coverage: Vancomycin/ Teicoplanin Gram negative: Tazocin/ Imipenem/ Polymyxin

DE-ESCALATION OF BROAD SPECTRUM ANTIBIOTIC THERAPY De-escalation: the practice of changing the antibiotic prescribed from initial, empiric broad-spectrum agent to one with a narrower and more focused spectrum once the pathogen has been isolated.

Uncomplicated UTI Nitrofurantoin

Chloramphenicol Staphylococcus aureus Enterococci Acinetobacter Coliforms

AVOID UNNECESSARY ANTIBIOTICS